Share
Salon
If the Pfizer and Moderna vaccines successfully put an end to the COVID-19 pandemic, as they seem poised to do, we will owe our salvation to the development of mRNA vaccines — an unprecedented, novel vaccine technology that may revolutionize how vaccines are made.
Indeed, an mRNA vaccine has never been mass-produced and licensed to treat an infectious disease. The mRNA vaccines to treat the novel coronavirus would be the first.
Yet understanding the quantum leap that mRNA vaccines represent requires understanding where we are right now. The biotechnology giants Moderna and Pfizer/BioNTech announced last month that they had seen promising results as they near the end of clinical trials for their vaccine candidates. Both vaccines are likely to be produced on a wide scale and distributed en masse to the public.
RELATED TOPICS:
Categories
Arizona Governor Vetoes Bill to Ban Teaching Antisemitism in Arizona’s Public Schools
US Rep. LaMonica McIver Indicted on Federal Charges From Skirmish at New Jersey Immigration Center
US Military Bases to Restore Names Changed After Racial Justice Protests, Trump Says
An Unknowing Fresno County Gave Community Medical $2.7M While Hospital Engaged in Kickback Scheme
Wall Street Ends Higher as Investors Track Progress of US-China Trade Talks
